NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
Speciality Medicines

Speciality Medicines

Open Date

Mar 20, 2026

Close Date

Mar 24, 2026

listed

Min Investment

₹2,48,000

Lot Size

1000 Shares

Issue Size

₹29.14 Cr

Price Range

₹117 - ₹117

Listing Date

Mar 30, 2026

IPO Doc

RHP PDF

About Speciality Medicines

Incorporated in the year 2021, Speciality Medicines Limited is a company involved in the marketing and distribution of finished formulations of speciality medicines across domestic and international markets. The company’s product portfolio includes a wide range of speciality pharmaceutical finished formulations products in various dosage forms, including tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions. The company operates in the following ways: contract manufacturing of finished formulations for international markets and marketing and distribution of sourced specialty pharmaceutical products. The company has expanded to the international market with registered/pending products in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia. The company’s distribution network has established strong relationships with over 20 states in India and over 35 countries worldwide. As of March 31, 2025, the company has 1 product registered overseas and 60 products in the registration process across 5 countries, generating revenue. As of August 31, 2025, the company had a total of 18 permanent employees in various departments.

Checklist Quality Analysis

Revenue Growth

Company Valuation

Earning Expansion

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.

0GMP

Speciality Medicines IPO - Issue Objectives

The company will utilise ₹12.68 crore for setting up an R&D center at Valsad, Gujarat. ₹2.99 crore will fund global product registration and development. The company will use ₹1.65 crore to fund its marketing and promotional activities. The company will utilise ₹8 crore for funding the working capital of the business. Part of the IPO proceeds will be used for general corporate purposes and issue expenses

Set up of R&D center

43.72%

Product registration and development

10.31%

Marketing expenses

5.72%

Working capital

27.59%

General corporate purposes

12.63%

1

Set up of R&D center

The company will utilise ₹12.68 crore for setting up an R&D center at Valsad, Gujarat.

43.72%
2

Product registration and development

₹2.99 crore will fund global product registration and development.

10.31%
3

Marketing expenses

The company will use ₹1.65 crore to fund its marketing and promotional activities.

5.72%
4

Working capital

The company will utilise ₹8 crore for funding the working capital of the business.

27.59%
5

General corporate purposes

Part of the IPO proceeds will be used for general corporate purposes and issue expenses

12.63%

IPO Subscription Status

Retails
0.82x
QIB
96.24x
NII
1.99x

Financials of Speciality Medicines

In Cr.

Revenue: ₹36.93

EBITDA: ₹6.51

Profit: ₹6.06

Total Income
EBITDA
Total Profit
Negative Value
Key Performance Indicator31-Oct-25 (In Cr.)31-Mar-25 (In Cr.)31-Mar-24 (In Cr.)
Revenue36.9358.5427.66
EBITDA6.519.095.26
Expenses
Profit After Tax6.068.612.93
Assets45.5739.9822.68
Net Worth36.4730.4215.06
Reserves30.0423.989.95
Borrowing4.815.052.86

Speciality Medicines - Promoter(s)

Parth B Goyani

Goyani Sumit Babubhai

Pre Issue Share Holding

59.28%

Post Issue Share Holding

43.44%

Contact Details

Speciality Medicines

913, One World West, S. No. 396, FP 119, Village - Vejalpur, Ahmadabad City, Ahmedabad, Gujarat, India - 380051.

Registrar Contact Details

Speciality Medicines IPO - FAQs

Speciality Medicines IPO is a SME IPO. The issue is priced at 117-₹124. The minimum order quantity is 1000 Shares. The IPO opens on 20 Mar, and closes on 24 Mar. Skyline Financial Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on SME.

Live IPOs

CMR Green Technologies logo

CMR Green Technologies

Mainboard
BSE
NSE
Open  Close3rd Jun 2026 - 5th Jun 2026
Issue Size630.88 Cr
Min. Qty78 Shares
Issue Price₹ 182.00
Live IPO
Vahh Chemicals logo

Vahh Chemicals

SME
Open  Close4th Jun 2026 - 8th Jun 2026
Issue Size13.45 Cr
Min. Qty2000 Shares
Issue Price₹ 60.00
Live IPO
UHM Vacation logo

UHM Vacation

SME
Open  Close4th Jun 2026 - 8th Jun 2026
Issue Size36.02 Cr
Min. Qty800 Shares
Issue Price₹ 157.00
Live IPO
Hexagon Nutrition logo

Hexagon Nutrition

Mainboard
Open  Close5th Jun 2026 - 9th Jun 2026
Issue Size138.87 Cr
Min. Qty333 Shares
Issue Price₹ 42.00
Live IPO
See All Live IPOs
IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.